• No geographical restrictions were set.
• All population-based studies reporting information about epidemiology, burden or costs of pertussis outbreaks were included.
RESULTS
• Out of the 425 records identified, 33 articles were included in the qualitative synthesis as 5 additional records identified through grey literature, describing 38 observational studies from 14 countries.
• Studies were heterogeneous in terms of settings. Consequently, outbreaks were classified:
 29 outbreaks occurred within a territory (country, region, county, city)
 4 outbreaks in a school  2 outbreaks at hospital  2 in an isolated community  1 outbreak at university
• Several articles described the most recent major pertussis outbreaks (e.g. California outbreak), while other articles described rather local outbreaks. This is presented in Table 1 . Less recent outbreaks are displayed in references . • The findings highlighted the need to improve monitoring epidemiology of pertussis, healthcare management and confirmed the need to have boosters with optimal timing within the routine immunization schedule.
• Additional research to be carried out, to support health authorities in the choice of the most suitable national vaccination program. • Study designs varied highly between articles. Among the selected articles, designs were the following:
 Retrospective/prospective analysis of surveillance database (30 references)
 Outbreak investigation (6 references)  Case-control studies (2 references)  Case series (1 reference)
• Pertussis outbreaks' key drivers, as identified by authors of publications, were classified in 3 different categories, as presented in Table 2 . Case-control study 4 Region
Case-control study 5 Counties
Retrospective case control study 6 Children's Hospital • Waning vaccine-mediated immunity in children who were being exposed more frequently to B. pertussis in community settings
• Possible pathogen-specific changes that may have influenced communicability and virulence and therefore impacted vaccine-specific immunity
• Low vaccination coverage
Pertussis disease underestimation
Lack of surveillance and monitoring 1, 19, 20, 21 • The surveillance systems in place may be useful for monitoring epidemiologic trends, but not outbreak Underreporting 1, 8, 18 • Many clinicians believe that pertussis vaccination is highly effective and, because of this, may not suspect or test for pertussis in vaccinated children.
• Vaccination results in a shorter, less severe illness, which may have contributed to minor cases being missed.
Difficulties in making the diagnosis 10, 11, 17, 20 • Culture is considered the golden standard for definite pertussis identification: it is 100% specific, however, sensitivity is low. This highlights the difficulty of having a definite diagnosis of pertussis
• PCR tests vary in specificity: potential misdiagnoses of pertussis using PCR (false positive).
• Serology: useful for confirming diagnosis. Drawback: antibodies caused by B.
pertussis infection cannot be distinguished from antibodies caused by vaccination.
High heterogeneity
Geographic differences
• People are generally well vaccinated in developed countries while vaccination coverage was not as high in developing countries.
Setting differences
• Size of the studied territory could go from a village/city to a state or even countries.
Studied population differences
• Most articles described the whole population of the setting (children and adults), however several studies only reported results for a specific subpopulation.
• Different vaccination recommendation in different studies • In addition, the need to develop new pertussis-containing vaccines that would provide long-lasting immunity was also discussed. 4, 5 • Table 3 summarizes study limitations as stated by authors and as identified by reviewers team.
• 12 articles did not publish any limitations, either on data retrieval or on data analysis, thus lowering the level of confidence in the reported results.
